Recommended application field: Agriculture, veterinary.

Advantages over analogues: Activity of the drug compared with the prototype (dibazolom) is 25% higher. Developed technical standards.

The development stage readiness: The working documentation is developed

Description of the development:
()
First developed an antimicrobial drug Dibaferol chemical that can be used to treat animal diseases caused by Escherichia coli, salmonella, and brucella pasterallami. Antimicrobial activity of the drug ranges from 7.8 to 62.5 ug / ml. Tested in the laboratory of virology and brucellosis Tajik Research Veterinary Institute. Acts are testing.

Information about newness of the development:
there are Ukrainian patents -- 1 items

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity

Photo

Country Tajikistan

For additional information turn to:
E-mail: gal@uintei.kiev.ua